Close Menu

NEW YORK (GenomeWeb) – The National Institutes of Health this month committed roughly $15 million over five years to St. Jude Children's Research Hospital and several collaborating institutions to support their research into how genomic variability influences the treatment of acute lymphoblastic leukemia (ALL).

With the funding, the partners have formed the Center for Precision Medicine in Leukemia (CPML), which is specifically tasked with identifying the mechanisms underlying the differential responses among pediatric and adult ALL patients to therapy.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.